Singapore, March 5, 2008: China-based Tianyin Pharmaceutical, a manufacturer and supplier of modernized traditional Chinese medicine (TCM), has appointed three independent board members: Dr Zunjian Zhang, Dr Jianping Hou and Mr James T McCubbin, who will serve along with Dr Guoqing Jiang and Mr Stewart Shiang Lor.

 

Dr Guoqing Jiang, MD & CEO will serve as Chairman of the Board. He led the group that purchased Tianyin Pharmaceutical in 2003. Before this, Dr Jiang served as CEO at Kelun Pharmaceutical, where he built the company from inception to become one of the leading producers of intravenous solution products and distributor of traditional Chinese medicine products and pharmaceuticals.

 

Mr Lor leverages over 20 years of experience in diverse disciplines, including corporate management, manufacturing and operations, international trade, corporate finance and investment, financial consulting, information technology as well as sales and marketing.

 

Dr Zunjian Zhang is currently a graduate school faculty advisor at China Pharmaceutical University. He is Executive Director at the Center for Instrument Analysis and in charge of the National Key Laboratory of Drug Quality Control and Pharmacovigilance of Ministry of Education at the university. In addition, he is a member of the Chinese Pharmacopoeia Commission and a SFDA expert review committee member for new drugs and health food products.

 

Dr Jianping Hou is currently a graduate school faculty advisor at Shaanxi University of Traditional Chinese Medicine. He has published dozens of peer-reviewed research papers and participated in compiling and editing a number of college textbooks regarding traditional Chinese medicine. Dr Hou is a principal investigator in more than 10 national research projects and has received the scientific achievement award from the State Administration of Traditional Chinese Medicine.

 

Mr James T McCubbin will serve as the Company's Audit Committee Chairman. Mr McCubbin currently holds the positions of Vice President, Chief Financial Officer, and Director at WidePoint Corporation. Previously, he held various senior financial management positions with several companies in the financial and government sectors.